GlassScriptPhysician profile
Lindsay Derus
NPI 1053677625
$5,128.25
in general payments reported to CMS, 2019-2025
16 companies · $56.73 in 2025
The $56.73 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $1,058 · 2022: $1,642 · 2023: $1,245 · 2025: $56.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $928 · Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $927.99 |
| Food and Beverage | $373.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,610.37 | 2022-2023 | Da Vinci Surgical System |
| Teleflex LLC | $1,135.78 | 2023 | Urolift |
| Boston Scientific Corporation | $984.96 | 2019-2020 | |
| Neotract INC. | $822.18 | 2019 | |
| Medtronic USA, INC. | $138.46 | 2020 | |
| Medtronic, INC. | $127.34 | 2022 | |
| Astellas Pharma US INC | $96.93 | 2019 | |
| Janssen Biotech, INC. | $64.45 | 2019-2020 | |
| Olympus America INC. | $34.38 | 2025 | Uretero-Reno Videoscope |
| Abbvie INC. | $22.40 | 2019 | |
| Urogen Pharma, INC. | $22.35 | 2025 | |
| Antares Pharma, INC. | $17.18 | 2019 | |
| Endo Pharmaceuticals INC. | $13.55 | 2019 | |
| Coloplast Corp | $13.31 | 2023 | Stenostent |
| Therapeuticsmd, INC. | $12.74 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Derus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.